Many drugs fail at a late stage in clinical trials because the drug is not as effective as previously anticipated or have serious side effects. This causes drug development companies a loss of $50,000 each day.
Wouldn’t it be nice to estimate drug effectiveness and side-effects accurately already during R&D phase?
Cytocast has a solution for you.
You can use Cytocast simulation to test your drug effect in-silico on multiple tissues, cell lines and patients before starting clinical trials. We just need as input, the list of proteins physically interacting with your drug candidate.
The Cytocast Cell Simulator© will report a list of functions and phenotypes affected by the drug candidate.
Check our Cytocast Whole Cell Simulator© page to learn more.